Cite

HARVARD Citation

    Lahcene, H. et al. (2020). Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice. Journal of oncology pharmacy practice. pp. 293-305. [Online]. 
  
Back to record